cro.directory
← Compare landing

ICON plc vs Premier Research

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryICON plcPremier Research
SummaryICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
Services
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • Companion Diagnostics Development
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • CNS Specialty Services
  • Cardiovascular & Metabolic Specialty Services
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
  • Device & Combination Product Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Peptide
  • Vaccine
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Ophthalmology
  • Women's Health
  • Oncology
  • Immunology
  • Neurology
  • Infectious Disease
  • Rare Disease
  • Dermatology
  • Women's Health
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Real-World Evidence (RWE) / Registries
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Preclinical (General)
  • Real-World Evidence (RWE) / Registries
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
Locations
  • Headquarters, Dublin, Ireland
  • Belgium, Belgium, Belgium
  • Bulgaria, Bulgaria, Bulgaria
  • Germany, Germany, Germany
  • Hungary, Hungary, Hungary
  • Italy, Italy, Italy
  • Netherlands, Netherlands, Netherlands
  • Poland, Poland, Poland
  • Romania, Romania, Romania
  • Slovakia, Slovakia, Slovakia
  • South Africa, South Africa, South Africa
  • Spain, Spain, Spain
  • Türkiye, Türkiye, Türkiye
  • United Kingdom, United Kingdom, United Kingdom
  • Australia, Australia, Australia
  • China, China, China
  • India, India, India
  • Japan, Japan, Japan
  • Korea, Korea, Korea
  • Malaysia, Malaysia, Malaysia
  • Taiwan, Taiwan, Taiwan
  • Argentina, Argentina, Argentina
  • Brazil, Brazil, Brazil
  • Chile, Chile, Chile
  • Colombia, Colombia, Colombia
  • Mexico, Mexico, Mexico
  • Belgium, Belgium, Belgium
  • Bulgaria, Bulgaria, Bulgaria
  • Germany, Germany, Germany
  • Hungary, Hungary, Hungary
  • Italy, Italy, Italy
  • Netherlands, Netherlands, Netherlands
  • Poland, Poland, Poland
  • Romania, Romania, Romania
  • Slovakia, Slovakia, Slovakia
  • South Africa, South Africa, South Africa
  • Spain, Spain, Spain
  • Türkiye, Türkiye, Türkiye
  • United Kingdom, United Kingdom, United Kingdom
  • Australia, Australia, Australia
  • China, China, China
  • India, India, India
  • Japan, Japan, Japan
  • Korea, Korea, Korea
  • Malaysia, Malaysia, Malaysia
  • Taiwan, Taiwan, Taiwan
  • Argentina, Argentina, Argentina
  • Brazil, Brazil, Brazil
  • Chile, Chile, Chile
  • Colombia, Colombia, Colombia
  • Mexico, Mexico, Mexico
  • United States, United States, United States
  • Headquarters, Morrisville, NC, United States
  • Southbank, Southbank, VIC, Australia
  • Sofia, Sofia, Bulgaria
  • Toronto, Mississauga, ON, Canada
  • Prague, Praha, Czech Republic
  • Paris, Paris, France
  • Darmstadt, Darmstadt, Germany
  • Budapest, Budapest, Hungary
  • Bengaluru, Bengaluru, India
  • Auckland, Auckland, New Zealand
  • Warsaw, Warszawa, Poland
  • Bucharest, Bucharest, Romania
  • Bratislava, Bratislava, Slovakia
  • Seoul, Seoul, South Korea
  • Madrid, Madrid, Spain
  • Taipei, Taipei, Taiwan
  • Kyiv, Kyiv, Ukraine
  • Wokingham, Wokingham, Berkshire, United Kingdom
CertificationsData not yet provided.Data not yet provided.

Find similar companies

ICON plc alternatives · Premier Research alternatives

Markdown mirror: /compare/iconplc/premier-research.md